Randomized, open-label study comparing Elvitegravir-Cobicistat-Tenofovir
Alafenamide-Emtricitabine (Genvoya) vs. Efavirenz-Tenofovir Disoproxil Fumarate-Lamivudine
(EFV-TDF-3TC) in patients starting ART on the day of HIV diagnosis.
Phase:
N/A
Details
Lead Sponsor:
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Collaborators:
Analysis Group, Inc. Brigham and Women's Hospital Gilead Sciences Weill Medical College of Cornell University